Consequently, this study aims to investigate the pathological role and potential mechanism of MCP-1 in T2DM, both in vivo and in vitro, with the aim of establishing a theoretical basis for the clinical prevention and treatment of T2DM. The gene discussed is CCL2; the disease is type 2 diabetes mellitus.